Key result
CMR shows no native T1 or ECV differences between asymptomatic female DMD carriers and controls.
Why the study?
Female carriers of dystrophin gene mutations were previously considered non-manifesting, but cardiomyopathy associated with muscular dystrophy and myocardial fibrosis has been described.
Does cardiovascular magnetic resonance imaging detect differences in myocardial native T1 relaxation time and extracellular volume in asymptomatic female carriers of Duchenne muscular dystrophy compared to healthy controls?
Case-Control (n=60)
No
Does cardiovascular magnetic resonance imaging detect differences in myocardial native T1 relaxation time and extracellular volume in asymptomatic female carriers of Duchenne muscular dystrophy compared to healthy controls?
In asymptomatic female carriers of Duchenne muscular dystrophy, CMR-derived native T1 mapping and ECV quantification did not show significant global or segmental myocardial fibrosis compared to healthy controls.
Answers are grounded in this paper and cite their sources.
CMR T1 mapping and ECV do not detect myocardial differences in asymptomatic DMD carriers; leaves open need for longitudinal or segmental assessment.
Background Female carriers of dystrophin gene mutations (DMD-FC) were previously considered non-manifesting, but in recent decades, cardiomyopathy associated with muscular dystrophy and myocardial fibrosis has been described. Our study aimed to assess prospectively myocardial fibrosis in asymptomatic DMD-FC compared to a sex-matched control group (CG) with similar age distribution using native T 1 mapping and extracellular volume (ECV) quantification by cardiovascular magnetic resonance (CMR) imaging. Materials and methods 38 DMD-FC with verified genetic mutation and 22 healthy volunteers were included. Using CMR, native T 1 relaxation time and ECV quantification were determined in each group. Late gadolinium enhancement (LGE) was assessed in all cases. Results There were 38 DMD-FC (mean age 39.1 ± 8.8 years) and 22 healthy volunteers (mean age 39.9 ± 12.6 years) imagined by CMR. The mean global native T 1 relaxation time was similar for DMD-FC and CG (1005.1 ± 26.3 ms vs. 1003.5 ± 25.0 ms; p-value = 0.81). Likewise, the mean global ECV value was also similar between the groups (27.92 ± 2.02% vs. 27.10 ± 2.89%; p-value = 0.20). The segmental analysis of mean ECV values according to the American Heart Association classification did not show any differences between DMD-FC and CG. There was a non-significant trend towards higher mean ECV values of DMD-FC in the inferior and inferolateral segments of the myocardium (p-value = 0.075 and 0.070 respectively). Conclusion There were no statistically significant differences in the mean global and segmental native T 1 relaxation times and the mean global or segmental ECV values. There was a trend towards higher segmental mean ECV values of DMD-FC in the inferior and inferolateral walls of the myocardium.
No takes yet. Share an insight, caveat, or question.
Masárová et al. (2023) conducted a case-control in Asymptomatic female carriers of Duchenne muscular dystrophy gene mutations (n=60). Cardiovascular magnetic resonance (CMR) imaging vs. Healthy volunteers was evaluated on Mean global native T1 relaxation time (p=0.81). Cardiovascular magnetic resonance imaging showed no significant differences in mean global native T1 relaxation time or extracellular volume between asymptomatic female carriers of Duchenne muscular dystrophy and healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: